Vor Biopharma (VOR)
(Delayed Data from NSDQ)
$1.80 USD
+0.04 (2.27%)
Updated May 3, 2024 04:00 PM ET
After-Market: $1.79 -0.01 (-0.56%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.37 | 0.00% |
Earnings Summary
For their last quarter, Vor Biopharma (VOR) reported earnings of -$0.39 per share, beating the Zacks Consensus Estimate of $-0.49 per share. This reflects a positive earnings surprise of 20.41%. Look out for VOR's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.37 per share, reflecting a year-over-year increase of 13.95%.
Earnings History
Price & Consensus
Zacks News for VOR
Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study
VOR: What are Zacks experts saying now?
Zacks Private Portfolio Services